Key facts
- L'Oreal is exploring options for US legal liabilities stemming from talc and other chemical ingredients.
- The company's US subsidiary is working with restructuring counsel Weil Gotshal & Manges and investment bank Ducera Partners.
- Mass lawsuits allege that L'Oreal's talc products have caused illness.
- Mattel shares fell about 3% after investor Ariel Investments urged the company to explore strategic alternatives.
- Ariel Investments, which owns a 5.4% stake in Mattel, believes the company's shares are undervalued.
- Authentic Brands previously approached Mattel about a potential acquisition valuing the company at about $6 billion or more.
L'Oreal is exploring options to address its mounting US legal liabilities stemming from the use of talc and other chemical ingredients in some of its cosmetic products, the Wall Street Journal reported. The company's US subsidiary has engaged restructuring counsel Weil Gotshal & Manges and investment bank Ducera Partners to navigate mass lawsuits alleging that its talc products have caused illness.
Separately, Mattel's shares fell about 3% on Tuesday after Ariel Investments, a shareholder with a 5.4% stake, urged the toymaker to explore strategic alternatives, including a sale, merger, or major asset divestiture. Ariel Investments stated that Mattel's shares remain significantly undervalued and could appeal to other toy companies, entertainment firms, or private equity firms. This is the second time this year an investor has pushed for a strategic review of Mattel. Last week, Authentic Brands reportedly approached Mattel about a potential acquisition valuing the company at about $6 billion or more. Mattel said it would consider the views expressed in Ariel Investments' letter while acting in the best interests of all shareholders.
